ArticleIntegrative cancer therapies

Long-Term Intracranial Progression-Free Survival in Lung Cancer Brain Metastases Extended Beyond 50 Months with Gubenxiaoyi Formula (GBXY): A Groundbreaking Case Study.

Zhengzheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.